Lonza works with Vertex Pharmaceuticals on cure for Type-1 diabetes at Portsmouth site
After installing new production lines in 2021 to manufacture components of COVID-19 vaccines, Swiss-based pharmaceutical giant Lonza is expanding its Portsmouth facilities again, this time to produce cell therapies that